'Pork Barrel' Means More Labs, Jobs

WASHINGTON—Seven universities and one hospital will receive $84.1 million this year in Energy Department funds to build research facilities. The congressional largesse, taken from funds initially budgeted for uranium enrichment programs, will mean hundreds of new jobs and more than one million additional square feet of laboratory, hospital and office space for American scientists. Critics see the appropriation as the latest example of "pork-barrel science"—a direct appeal to Congress

Written byBob Westgate
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Critics see the appropriation as the latest example of "pork-barrel science"—a direct appeal to Congress for construction funds in the absence of peer review for quality and need. Supporters argue that politics should play a part in the appropriation of federal funds and that lesser-known institutions deserve a slice of the federal pie as they try to strengthen their programs. There is no formal peer-review process within federal agencies to fund university facilities because, officially, there are no federal funds available for such purposes.

A look at the eight projects shows that the federal government is only one of many sources of funding for university construction. In fact, federal funds often stimulate larger contributions from private, state and industrial sources.

The $22.9 million that the University of Oregon will receive this year brings to $33.9 million the total federal contribution to the University's $45.3 million graduate science technology center in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies